References
- Baldwin P J, van der Burg S H, Boswell C M, Offringa R, Hickling J K, Dobson J, et al. Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clinical Cancer Research 2003; 9: 5205–5013
- Barton S E, Maddox P H, Jenkins D, Edwards R, Cuzick J, Singer A. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?. Lancet 1988; 2: 652–654
- Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss R E, Jellum E, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. British Journal of Cancer 2002; 87: 61–64
- Chiesa-Vottero A, Dvoretsky P M, Hart W R. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. American Journal of Surgical Pathology 2006; 30: 310–318
- Goffin F, Mayrand M H, Gauthier P, Alobaid A, Lussier C, Provencher D, et al. High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. Journal of Medical Virology 2006; 78: 814–819
- Jones R W. Vulval intraepithelial neoplasia: current perspectives. European Journal of Gynaecological Oncology 2001; 22: 393–402
- Jones R W, Rowan D M, Stewart A W. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstetrics and Gynecology 2005; 106: 1319–1326
- Joura E A, Leodolter S, Hernandez-Avila M, Wheeler C M, Perez G, Koutsky L A, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007; 369: 1693–1702
- McNally O M, Mulvany N J, Pagano R, Quinn M A, Rome R M. VIN 3: a clinicopathologic review. International Journal of Gynecological Cancer 2002; 12: 490–495
- Modesitt S C, Waters A B, Walton L, Fowler W C, Jr, Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstetrics and Gynecology 1998; 92: 962–966
- Munoz N, Bosch F X, de Sanjose S, Herrero R, Castellsague X, Shah K V, , International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 2003; 348: 518–527
- Poulsen H, Junge J, Vyberg M, Horn T, Lundvall F. Small vulvar squamous cell carcinomas and adjacent tissues. A morphologic study. Acta Pathologica, Microbiologica et Immunologica Scandinavica 2003; 111: 835–842
- Ridley C M. The aetiology of vulval neoplasia. British Journal of Obstetrics and Gynaecology 1994; 101: 655–657
- Rodolakis A, Diakomanolis E, Vlachos G, Iconomou T, Protopappas A, Stefanidis C, et al. Vulvar intraepithelial neoplasia (VIN) – diagnostic and therapeutic challenges. European Journal of Gynaecological Oncology 2003; 24: 317–322
- Stanley M. Genital human papillomavirus infections-current and prospective therapies. Journal of the National Cancer Institute Monograph 2003; 31: 117–124
- Sykes P, Smith N, McCormick P, Frizelle F A. High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989–1999. Australian and New Zealand Journal of Obstetrics and Gynaecology 2002; 42: 69–74
- Syrjanen K. Anogenital human papilloma virus and the problem of persistence. European Journal of Dermatology 1998; 8: S5–S7
- Szarewski A, Jarvis M J, Sasieni P, Anderson M, Edwards R, Steele S J, et al. Effect of smoking cessation on cervical lesion size. Lancet 1996; 347: 941–943
- Woodman C B, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 1831183–1831186